From the Department of Scientific Computing (S.E., S.G., M.T., M.D.H.B., N.S.C., P.H., L.M.W.) and National Co-ordinating Centre for the Physics of Mammography (K.C.Y.), Royal Surrey NHS Foundation Trust, Egerton Road, Guildford GU2 7XX, England; and Centre for Vision, Speech and Signal Processing (M.D.H.B.) and Department of Physics (K.C.Y.), University of Surrey, Guildford, England.
Radiol Artif Intell. 2024 Jul;6(4):e230431. doi: 10.1148/ryai.230431.
Purpose To develop an artificial intelligence (AI) deep learning tool capable of predicting future breast cancer risk from a current negative screening mammographic examination and to evaluate the model on data from the UK National Health Service Breast Screening Program. Materials and Methods The OPTIMAM Mammography Imaging Database contains screening data, including mammograms and information on interval cancers, for more than 300 000 female patients who attended screening at three different sites in the United Kingdom from 2012 onward. Cancer-free screening examinations from women aged 50-70 years were performed and classified as risk-positive or risk-negative based on the occurrence of cancer within 3 years of the original examination. Examinations with confirmed cancer and images containing implants were excluded. From the resulting 5264 risk-positive and 191 488 risk-negative examinations, training ( = 89 285), validation ( = 2106), and test ( = 39 351) datasets were produced for model development and evaluation. The AI model was trained to predict future cancer occurrence based on screening mammograms and patient age. Performance was evaluated on the test dataset using the area under the receiver operating characteristic curve (AUC) and compared across subpopulations to assess potential biases. Interpretability of the model was explored, including with saliency maps. Results On the hold-out test set, the AI model achieved an overall AUC of 0.70 (95% CI: 0.69, 0.72). There was no evidence of a difference in performance across the three sites, between patient ethnicities, or across age groups. Visualization of saliency maps and sample images provided insights into the mammographic features associated with AI-predicted cancer risk. Conclusion The developed AI tool showed good performance on a multisite, United Kingdom-specific dataset. Deep Learning, Artificial Intelligence, Breast Cancer, Screening, Risk Prediction ©RSNA, 2024.
开发一种人工智能(AI)深度学习工具,能够根据当前阴性筛查乳腺 X 光检查预测未来乳腺癌风险,并评估该模型在英国国家卫生服务乳腺筛查计划数据上的表现。
OPTIMAM 乳腺成像数据库包含来自英国三个不同地点的超过 300000 名女性筛查数据,包括乳腺 X 光片和间隔期癌症信息。对 50-70 岁女性进行无癌筛查检查,并根据原始检查后 3 年内癌症的发生情况将其分为风险阳性或风险阴性。排除有确诊癌症的检查和含有植入物的图像。从 5264 例风险阳性和 191488 例风险阴性检查中,生成了用于模型开发和评估的训练集(=89285)、验证集(=2106)和测试集(=39351)。该 AI 模型通过乳腺 X 光片和患者年龄来预测未来癌症的发生。在测试数据集上使用接收者操作特征曲线下面积(AUC)评估性能,并在亚组间进行比较以评估潜在偏差。还探索了模型的可解释性,包括使用显著图。
在独立测试集中,AI 模型的总体 AUC 为 0.70(95%CI:0.69,0.72)。在三个地点、患者种族或年龄组之间,模型性能没有差异。显著图和样本图像的可视化提供了与 AI 预测的癌症风险相关的乳腺特征的见解。
该开发的 AI 工具在多站点、英国特有的数据集上表现良好。